| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |